Neonatal Hypoglycemia
Miami Neonatology 2018 — 42nd Annual International Conference

You must be signed in to view this CME course.

In this activity, Paul J. Rozance, MD, reviews the differences, benefits, and when to use the American Academy of Pediatrics (AAP) and Pediatric Endocrine Society (PES) guidelines for screening, evaluation, and management of hypoglycemia, while highlighting the importance of treating asymptomatic hypoglycemia. 

In the companion, Neonatal Hyperglycemia in the ELBW Infant, Dr. Rozance discusses strategies to prevent and treat hyperglycemia in extremely low-birth-weight (ELBW) and preterm infants. He identifies risk factors, the long-term effects of hyperglycemia, and the rationale for treating and preventing this biochemical disorder. 

Course Credit:

0.50 AANP Contact Hour
0.50 AMA PRA Category 1 CreditTM
0.50 ANCC Contact Hour
0.50 CA-BRN Contact Hour
0.50 CDR Contact Hour


Opens: 2019-02-22
Closes: 2021-02-22

Target Audience:

This activity was developed for physicians, pediatric nurse practitioners, nurses, registered dietitians, and other health care professionals who have an interest in newborns, infants and toddlers.

This activity is supported by an educational grant from Mead Johnson Nutrition.
  • Paul J. Rozance, MD

    The Frederick C. Battaglia Endowed Chair in Neonatology
    Children’s Hospital Colorado
    Professor, Department of Pediatrics
    Perinatal Research Center
    University of Colorado School of Medicine
    Aurora, Colorado

Learning Objectives

  • Treat asymptomatic neonatal hypoglycemia with buccal dextrose gel
  • Develop patient-specific approaches to intravenous dextrose therapy for neonatal hypoglycemia

Faculty Disclosures

Paul J. Rozance, MD

  • Research Support
    • Nova Biomedica – Clinical area: beta-cell function
  • Consultant
    • Xeris Pharmaceutical – Clinical area: congenital genetic hyperinsulinemia

Accreditation and Certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Annenberg Center for Health Sciences is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.
This program is designated for up to 0.50 contact hour. Program ID# 5622-EM5.
The Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 0.50 contact hour may be earned for successful completion of this activity.
Provider is approved by the California Board of Registered Nursing, Provider #13664, for 0.50 contact hour.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
Annenberg Center for Health Sciences at Eisenhower is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 0.50 hour continuing professional education unit (CPEU) for completion of this program/material.
Provider Number AC857; Activity Number 146359.
Learners may submit additional evaluations of the quality of this program/material to

Additional Content Planners

Erin Allen, MS, RD, LDN (RD Reviewer)
No significant relationships to disclose.

Victoria Anderson (Medical Writer)
  • Individual Stockholder
    • Abbott – clinical area: N/A
    • AbbVie – clinical area: N/A

Heather M. Jimenez, FNP-C (Nurse Planner)
No significant relationships to disclose.

Annenberg Center for Health Sciences

All staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.